Boehringer Mannheim and Eli Lilly and Company Announce Diabetes-Care Alliance.KOBE, Japan--(HealthWire)--Nov. 7, 1994-- Boehringer Mannheim and Eli Lilly and Company Eli Lilly and Company (NYSE: LLY) is a global pharmaceutical company and one of the world's largest corporations. Eli Lilly's global headquarters is located in Indianapolis, Indiana, in the United States. today announced that they have agreed in principle to develop joint marketing efforts and other collaborative programs intended to maximize the companies' abilities to deliver diabetes care throughout the world. Lilly and Boehringer Mannheim are nearing completion of agreements for specific programs in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. and several other countries around the world. Discussions are in various stages in more than 20 additional countries. The alliance was announced at the triennial tri·en·ni·al adj. 1. Occurring every third year. 2. Lasting three years. n. 1. A third anniversary. 2. A ceremony or celebration occurring every three years. International Diabetes Federation The International Diabetes Federation (IDF) is a worldwide alliance of 200 diabetes associations in more than 150 countries, who have come together to enhance the lives of people with diabetes everywhere. For over 50 years, IDF has been at the vanguard of global diabetes advocacy. Congress in Kobe, Japan. The companies expect that this collaboration will involve sharing of information between the two companies regarding their respective diabetes-care products. It is expected in the United States, for example, that Lilly sales representatives will begin to support Boehringer Mannheim's Accu-Chek(R) blood glucose monitoring blood glucose monitoring Sugar monitoring Lab medicine The periodic testing of serum glucose in Pts known to have DM. See Bedside glucose monitoring, Beta cell implants, Diabetes, Glucometer, Glycosylated hemoglobin, Non-Invasive glucose monitoring. devices and sales representatives from Boehringer Mannheim will support Lilly's Humulin(R) insulin products. "Recently, the pharmaceutical environment has been one in which companies have worked to bolster their pipelines through the outright acquisition of products and technologies," said Steffan Ek, president of diabetes care at Boehringer Mannheim. "This new model allows companies to work together to bring a complete portfolio of disease-management solutions to health care providers, while fostering the corporate individuality that drives the development of new products and technologies." Randall L. Tobias Randall L. Tobias (born March 20, 1942) is a former chief executive officer of Eli Lilly and Company who became the first United States Director of Foreign Assistance, and served concurrently as the Administrator of the U.S. , chairman and chief executive officer of Lilly, commented, "I fully expect this collaboration to significantly enhance our ability to develop a more integrated method of managing diabetes as well as our ability to develop new products that will improve the lives of individuals who must live with the disease." Both Ek and Tobias are attending the IDF (Intermediate Distribution Frame) A wiring rack located between the MDF (main distribution frame) and the intended end user devices (telephones, routers, PCs, etc.). Cables run from the outside world to the MDF and then to the IDFs. See MDF and wiring rack. Congress in Japan. According to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. the companies, the Boehringer Mannheim-Lilly alliance is an example of the integration taking place in disease management programs. The companies are working with health care professionals to enhance awareness and education about diabetes care, service to patients, and development of new diabetes-care products in order to provide total disease-management for patients with diabetes. Using the concept of total disease management, this alliance allows representatives from both companies to talk with diabetes health Diabetes Health magazine, published by King's Publishing in California, United States, is one of the US's biggest magazines focusing on diabetes and the complications that are the every day concern of people with this disease and also their families and friends. care professionals about achieving better glucose control in patients through insulin therapy and frequent blood glucose blood glucose Diabetology The principal sugar produced by the body from food–especially carbohydrates, but also from proteins and fats; glucose is the body's major source of energy, is transported to cells via the circulation and used by cells in the presence testing. Diabetes is a common chronic disorder Chronic Disorder is a rock/punk band formed in the early 1980s in Connecticut, now active in Seattle. Discography
Boehringer Mannheim is the global leader in the research, development, and marketing of blood glucose monitors. The company's monitoring and analytical products are designed to effectively diagnose patients and enable them to take control of their therapy as they work more closely with health care providers to personally manage their disease. Lilly, a world leader in the pharmaceutical industry, has been a leader in diabetes care for more than 70 years. Lilly developed the method for mass production of the first commercial insulin product in 1923. Over the years, the company has developed more than 40 insulin products and has provided new treatments for diabetes that are safer, more effective, and more convenient for patients. Boehringer Mannheim-Therapeutics, Boehringer Mannheim-Diagnostics, and DePuy Orthopaedics are divisions of Corange Limited, a leader in diagnostics, biochemicals, pharmaceuticals, and orthopaedics. CONTACT: Eli Lilly and Company, Indianapolis
Robert Grupp, Tel: +1 (317) 277 3866
Fax: +1 (317) 277 2162
Boehringer Mannheim Corp.
Tom Watlington, Tel: +1 (317) 845 7166
Fax: +1 (317) 576 4816
Corange London Ltd.
Charlotte Dexter, Tel: +44 (71) 355 1500
Fax: +44 (71) 495 2739
|
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion